Trade Summary

3 days ago, LYNCH TIMOTHY P, serving as 10% owner Owner at AEON Biopharma, Inc. (AEON), purchased 1,150,000 shares at $0.21 per share, for a total transaction value of $243,455.00. Following this transaction, LYNCH TIMOTHY P now holds 6,500,000 shares of AEON.

This purchase represents a 21.50% increase in LYNCH TIMOTHY P's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 19, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 21, 2026 at 7:41 PM ET, 2 days after the trade was made.

AEON Biopharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.